Functionalized nanoparticles for intracellular delivery of biologically active molecules
Functionalized biocompatible nanoparticles capable of penetrating through a mammalian cell membrane and delivering intracellularly a plurality of bioactive molecules for modulating a cellular function are disclosed herein The functionalized biocompatible nanoparticles comprise: a central nanoparticle ranging in size from about 5 to about 50 nm and having a polymer coating thereon, a plurality of functional groups covalently attached to the polymer coating, wherein the plurality of bioactive molecules are attached to the plurality of the functional groups, and wherein the plurality of bioactive molecules include at least a peptide and a protein, and wherein the peptide is capable of penetrating through the mammalian cell membrane and entering into the cell, and wherein the protein is capable of providing a new functionality within the cell. The protein may be a transcription factor selected from the group consisting of Oct4, Sox2, Nanog, Lin28, cMyc, and Klf4.
1. A functionalized biocompatible nanoparticle for penetrating through a mammalian cell membrane and delivering intracellularly a bioactive molecule for modulating a cellular function, said functionalized biocompatible nanoparticle comprising:
a central nanoparticle having one or more functional groups attached thereto,
a cell penetrating peptide for penetrating through a membrane of said mammalian cell, wherein said cell penetrating peptide is attached via a first linker molecule to a first functional group on said central nanoparticle, and
a bioactive molecule for modulating a function of said mammalian cell, wherein said bioactive molecule is attached via a second linker molecule to a second functional group on said central nanoparticle;
wherein said cell penetrating peptide and said bioactive molecule are independently attached to said central nanoparticle via attachment of said cell penetrating peptide to said first linker molecule and attachment of said bioactive molecule to said second linker molecule.
2. The functionalized biocompatible nanoparticle of claim 1 wherein said central nanoparticle has a size ranging from 5 to 50 nm.
3. The functionalized biocompatible nanoparticle of claim 1 wherein said first functional group is the same as said second functional group.
4. The functionalized biocompatible nanoparticle of claim 1 wherein said central nanoparticle further comprises a polymer coating.
5. The functionalized biocompatible nanoparticle of claim 4 wherein one or both of said first functional group and said second functional group are attached to said polymer coating on said central nanoparticle.
6. The functionalized biocompatible nanoparticle of claim 1 wherein said central nanoparticle comprises iron.
7. The functionalized biocompatible nanoparticle of claim 1 wherein said first linker molecule has a first length, wherein said second linker molecule has a second length, and wherein said first length is greater than said second length.
8. The functionalized biocompatible nanoparticle of claim 1 wherein said cell penetrating peptide includes from five basic amino acids to nine basic amino acids.
9. The functionalized biocompatible nanoparticle of claim 1 wherein said cell penetrating peptide includes nine or more basic amino acids.
10. The functionalized biocompatible nanoparticle of claim 1 wherein said bioactive molecule is a transcription factor.
11. The functionalized biocompatible nanoparticle of claim 10 wherein said transcription factor is selected from the group consisting of Oct4, Sox2, Nanog, Lin28, cMyc, and Klf4.
12. A method for changing a cellular functionality of a mammalian cell, said method comprising contacting a mammalian cell with a functionalized biocompatible nanoparticle of claim 1 thereby changing a cellular functionality of said mammalian cell.
13. The method of claim 12 wherein said change in cellular functionality of said mammalian cell is selected from the group consisting of a change in a physico-chemical property of said mammalian cell, a change in a proliferative property of said mammalian cell, a change in survivability of said cell, a change in a morphological property of said mammalian cell, and a change in the differentiation state of said mammalian cell.
14. The method of claim 13 wherein said change in the differentiation state of said mammalian cell comprises the conversion of said mammalian cell into a stem cell.